ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate
TL;DR: ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate (CAS 213334-40-8) is a chemical compound with molecular formula C19H22N6O4S and molecular weight 430.14 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate
Also Known As: ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate, Ehtyl 3-methyl-8-[p-sulfamylphenethylamino]pyrido[2,3-b]pyrazine, ethyl(3-methyl-8-{[2-(4-sulfamoylphenyl)ethyl]amino}pyrido[2,3-b]pyrazin-6-yl)carbamate, 4-([(6-Amino-2,3-diphenylpyrido[2,3-b]pyrazin-8-yl)amino]methyl)benzenesulfonamide, ethyl (3-methyl-8-((4-sulfamoylphenethyl)amino)pyrido[2,3-b]pyrazin-6-yl)carbamate
| Molecular Formula | C19H22N6O4S |
|---|---|
| Molecular Weight | 430.14 g/mol |
| LogP | 1.7 |
| Topological Polar Surface Area | 158.0 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 9 |
| Rotatable Bonds | 8 |
| Exact Mass | 430.14233 |
| Heavy Atoms | 30 |
| Complexity | 664.0 |
Chemical Identifiers
| CAS Number | 213334-40-8 |
|---|---|
| SMILES | CCOC(=O)NC1=NC2=NC(=CN=C2C(=C1)NCCC3=CC=C(C=C3)S(=O)(=O)N)C |
| InChIKey | PEPYZZRSMZCGKY-UHFFFAOYSA-N |
Product Overview
ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate (CAS 213334-40-8), with molecular formula C19H22N6O4S and molecular weight 430.14 g/mol. IUPAC: ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate.
Chemical Property Profile of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate
Property Insights of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate
The XLogP value of 1.7 suggests moderate lipophilicity, balancing water solubility and membrane permeability for ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate. The TPSA of 158.0 Ų indicates high polarity, suggesting ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate may have limited membrane permeability but good aqueous solubility. Following Lipinski's Rule of Five, ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate has 3 hydrogen bond donor(s) and 9 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate?
The CAS number of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate is 213334-40-8.
What is the molecular formula of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate?
The molecular formula of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate is C19H22N6O4S.
What is the molecular weight of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate?
The molecular weight of ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate is 430.14 g/mol.
Where can I buy ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate?
You can request a quote for ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate?
Yes, KEHONG BIO provides custom synthesis services for ethyl N-[3-methyl-8-[2-(4-sulfamoylphenyl)ethylamino]pyrido[2,3-b]pyrazin-6-yl]carbamate and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.